Patents by Inventor Michael DeVries

Michael DeVries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DISPOSABLE WRIST SUPPORT
    Publication number: 20120245503
    Abstract: A disposable wrist support includes a body formed of a flexible impervious elastomer material and configured to be worn about a wearer's wrist. At least one support device is attached to the body. The support device is configured to provide support to the wearer's wrist.
    Type: Application
    Filed: March 13, 2012
    Publication date: September 27, 2012
    Inventor: Michael DeVries
  • Pharmaceutically Active Compounds
    Publication number: 20100035891
    Abstract: Compounds of the formula (I): wherein R1, R2, R4 and R13 are as defined or a pharmaceutically or veterinarily acceptable salt or polymorph thereof, or a pharmaceutically or veterinarily acceptable solvate or pro-drug thereof: are potent and selective inhibitors of type 5 cyclic guanosine 3?,5?-monophosphate phosphodiesterase (cGMP PDE5) and have utility in the treatment of, inter alia, male erectile dysfunction (MED) and female sexual dysfunction (FSD).
    Type: Application
    Filed: May 20, 2009
    Publication date: February 11, 2010
    Inventors: Mark Edward Bunnage, Keith Michael DeVries, Laurence James Harris, Philip Charles Levett, John Paul Mathias, Joanna Teresa Negri, Stephen Derek Albert Street, Albert Shaw Wood
  • Process for preparing pharmaceutically active compounds
    Patent number: 7176311
    Abstract: A process for the preparation of Compounds of the formula (1): wherein R1, R2, R4 and R13 are as defined or a pharmaceutically or veterinarily acceptable salt or polymorph thereof, or a pharmaceutically or veterinarily acceptable solvate or pro-drug thereof: are potent and selective inhibitors of type 5 cyclic guanosine 3?,5?-monophosphate phosphodiestbrase (cGMP PDE5) and have utility in the treatment of, inter alia, male erectile dysfunction (MED) and female sexual dysfunction (FSD).
    Type: Grant
    Filed: January 6, 2004
    Date of Patent: February 13, 2007
    Assignee: Pfizer Inc.
    Inventors: Mark Edward Bunnage, Keith Michael DeVries, Laurence James Harris, Philip Charles Levett, John Paul Mathias, Joanna Teresa Negri, Stephen Derek Albert Street, Albert Shaw Wood
  • Systems and methods for performing minimally invasive cardiac medical procedures
    Publication number: 20050020968
    Abstract: Systems and methods for creating space within the chest cavity to more easily perform minimally invasive cardiac procedures.
    Type: Application
    Filed: August 13, 2004
    Publication date: January 27, 2005
    Inventors: Walid Aboul-Hosn, Michael DeVries, Bruce Baker, William Kanz, Jonathan Spangler
  • Systems for performing minimally invasive cardiac medical procedures
    Patent number: 6814713
    Abstract: Systems and methods for creating space within the chest cavity to more easily perform minimally invasive cardiac procedures.
    Type: Grant
    Filed: April 25, 2002
    Date of Patent: November 9, 2004
    Assignee: A-Med Systems, Inc.
    Inventors: Walid Aboul-Hosn, Michael DeVries, Bruce Baker, William Kanz, Jonathan Spangler
  • Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
    Patent number: 6809200
    Abstract: A process is provide for the preparation of compounds of formula (I) herein comprising reacting a compound of formula (III), (IV) or (V) wherein the variables are as defined in the specification. The reaction is conducted in the presence of −OR3 and a hydroxide trapping agent or in the case of compounds of formula (IV) reacting in the presence of an auxiliary base and a hydroxide trapping agent.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: October 26, 2004
    Assignee: Pfizer Inc.
    Inventors: Charlotte Moira Norfor Allerton, Christopher Gordon Barber, Keith Michael DeVries, Laurence James Harris, Philip Charles Levett, Joanna Teresa Negri, David James Rawson, Albert Shaw Wood
  • Pharmaceutically active compounds
    Publication number: 20040152712
    Abstract: Compounds of the formula (1): 1
    Type: Application
    Filed: January 6, 2004
    Publication date: August 5, 2004
    Applicant: Pfizer Inc.
    Inventors: Mark Edward Bunnage, Keith Michael DeVries, Laurence James Harris, Philip Charles Levett, John Paul Mathias, Joanna Teresa Negri, Stephen Derek Albert Street, Albert Shaw Wood
  • Pharmaceutically active compounds
    Patent number: 6677335
    Abstract: Compounds of the formula (I): wherein R1, R2, R4 and R13 are as defined or a pharmaceutically or veterinarily acceptable salt or polymorph thereof, or a pharmaceutically or veterinarily acceptable solvate or pro-drug thereof: are potent and selective inhibitors of type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP PDE5) and have utility in the treatment of, inter alia, male erectile dysfunction (MED) and female sexual dysfunction (FSD).
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: January 13, 2004
    Assignee: Pfizer Inc
    Inventors: Mark Edward Bunnage, Keith Michael DeVries, Laurence James Harris, Philip Charles Levett, John Paul Mathias, Joanna Teresa Negri, Stephen Derek Albert Street, Albert Shaw Wood
  • Systems and methods for performing minimally invasive cardiac medical procedures
    Publication number: 20030023201
    Abstract: Systems and methods for creating space within the chest cavity to more easily perform minimally invasive cardiac procedures.
    Type: Application
    Filed: April 25, 2002
    Publication date: January 30, 2003
    Applicant: A-Med Systems, Inc.
    Inventors: Walid Aboul-Hosn, Michael DeVries, Bruce A. Baker, William Kanz, Jonathan Spangler
  • Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditions
    Patent number: 6380204
    Abstract: The present invention relates to novel atropisomers of 3-heteroaryl-4(3H)-quinazolinones of the formula Ia, and their pharmaceutically acceptable salts, and pharmaceutical compositions and methods of treating neurodegenerative and CNS-trauma related conditions.
    Type: Grant
    Filed: January 13, 2000
    Date of Patent: April 30, 2002
    Assignee: Pfizer INC
    Inventors: Bertrand Leo Chenard, Keith Michael Devries, Willard McKowan Welch, Jr.
  • Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
    Publication number: 20020038024
    Abstract: A process is provided for the preparation of compounds of formula (I) herein comprising reacting a compound of formula (II), (III), (IV) or (V) in the presence of −OR3 and a hydroxide trapping agent or in the case of compounds of formula (IV) reacting in the presence of an auxiliary base and a hydroxide trapping agent (i.e. −OR3 is substituted by the auxiliary base), wherein X is a leaving group and R1 to R4 are as defined.
    Type: Application
    Filed: July 26, 2001
    Publication date: March 28, 2002
    Inventors: Charlotte Moira Norfor Allerton, Christopher Gordon Barber, Keith Michael Devries, Laurence James Harris, Philip Charles Levett, Joanna Teresa Negri, David James Rawson, Albert Shaw Wood
  • Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-receptor antagonists
    Patent number: 6306864
    Abstract: The present invention relates to novel atropisomers of 2-(aryl or heteroaryl)-3-aryl-4(3H)-quinazolinones of the formula I, and their pharmaceutically acceptable salts, and pharmaceutical compositions and methods of treating neurodegenerative and CNS-trauma related conditions.
    Type: Grant
    Filed: January 13, 2000
    Date of Patent: October 23, 2001
    Assignee: Pfizer Inc.
    Inventors: Willard McKowan Welch, Jr., Keith Michael DeVries